AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15962646 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol by patient‐controlled sedation (PCS)
Number of subjects: 110
Study 15962646 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam
Number of subjects: 110
Study 15962646 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study 12466363 — intervention group
Group type: EXPERIMENTAL
Intervention: hypocaloric diet + metformin
Number of subjects: 20
Study 12466363 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 9989537 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 97
Study 9989537 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 97
Study 7591356 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly preannounced urine testing
Number of subjects: 74
Study 7591356 — intervention group
Group type: COMPARATOR
Intervention: Weekly unannounced urine testing
Number of subjects: 74
Study 2321612 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive postpartum education and support for breastfeeding
Number of subjects: 97
Study 2321612 — intervention group
Group type: COMPARATOR
Intervention: Routine assistance provided by obstetrical nurses
Number of subjects: 97
Study 87277 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, adriamycin, vincristine, and prednisone)
Number of subjects: 24
Study 87277 — intervention group
Group type: EXPERIMENTAL
Intervention: HOP (adriamycin, vincristine, and prednisone)
Number of subjects: 24
Study 87277 — intervention group
Group type: COMPARATOR
Intervention: COP plus bleomycin (cyclophosphamide, vincristine, prednisone, and bleomycin)
Number of subjects: 24
Study 87277 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 24
Study 31478755 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (VISBIOME)
Number of subjects: 13
Study 31478755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 28989802 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel loading dose
Number of subjects: 303
Study 28989802 — intervention group
Group type: COMPARATOR
Intervention: Control (maintenance dose)
Number of subjects: 303
Study 26621682 — intervention group
Group type: EXPERIMENTAL
Intervention: Estriol (8 mg daily) plus glatiramer acetate (20 mg daily)
Number of subjects: 164
Study 26621682 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus glatiramer acetate (20 mg daily)
Number of subjects: 164
Study 25437725 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐to‐one antenatal breastfeeding support and education session
Number of subjects: 469
Study 25437725 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 469
Study 21257800 — intervention group
Group type: EXPERIMENTAL
Intervention: PM101 Premixed Injection (150 mg)
Number of subjects: 88
Study 21257800 — intervention group
Group type: COMPARATOR
Intervention: Intravenous amiodarone (150 mg)
Number of subjects: 88
Study 19190970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablation of Barrett's esophagus with Argon plasma coagulation (APC)
Number of subjects: 9
Study 17971670 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronically stored nosodes treatment
Number of subjects: 15
Study 17971670 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 15
Study 15857878 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheobronchography
Number of subjects: 16
Study 15857878 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 16
Study 15857878 — intervention group
Group type: COMPARATOR
Intervention: Radiation doses
Number of subjects: 16
Study 15857878 — intervention group
Group type: COMPARATOR
Intervention: Correlation between investigations
Number of subjects: 16
Study 12032009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tramadol 2 mg/kg
Number of subjects: 81
Study 12032009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tramadol 1 mg/kg
Number of subjects: 81
Study 12032009 — intervention group
Group type: COMPARATOR
Intervention: Rescue analgesia (morphine patient‐controlled analgesia or oral oxycodone)
Number of subjects: 81
Study 9149248 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine-125 (125 I) brachytherapy
Number of subjects: 24
Study 9149248 — intervention group
Group type: COMPARATOR
Intervention: Control nonimplant group
Number of subjects: 24
Study 8182225 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic group (breast milk from mothers on an exclusion diet or extensively hydrolyzed formula, acaricide treatment, polyvinyl-covered mattresses)
Number of subjects: 120
Study 8182225 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional feeding, no environmental control)
Number of subjects: 120
Study 3296668 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic treatment
Number of subjects: 83
Study 3296668 — intervention group
Group type: COMPARATOR
Intervention: Beta-blocker treatment
Number of subjects: 83
Study 31098739 — intervention group
Group type: EXPERIMENTAL
Intervention: Colla corii asini (CCA) treatment, 15g daily for 4 weeks
Number of subjects: 20
Study 31098739 — intervention group
Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 20
Study 30028477 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology massage (two times for 20 min at 3-hour intervals)
Number of subjects: 75
Study 30028477 — intervention group
Group type: COMPARATOR
Intervention: Placebo massage (unspecified point on the foot)
Number of subjects: 75
Study 30028477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 75
Study 27235524 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic treatment with a double elasticated bandage for four weeks
Number of subjects: 60
Study 27235524 — intervention group
Group type: COMPARATOR
Intervention: Immobilisation in a below-knee walking cast for four weeks
Number of subjects: 60
Study 24604461 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) in combination with systemic family therapy (SFT)
Number of subjects: 249
Study 24604461 — intervention group
Group type: COMPARATOR
Intervention: Conventional postpartum care
Number of subjects: 249
Study 22650799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine low dose (3 μg/kg/h for 10 min followed by 0.17 μg/kg/h for 50 min)
Number of subjects: 24
Study 22650799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine middle dose (6 μg/kg/h for 10 min followed by 0.34 μg/kg/h for 50 min)
Number of subjects: 24
Study 22650799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine high dose (3.7 μg/kg/h for 35 min followed by 0.7 μg/kg/h for 25 min)
Number of subjects: 24
Study 22650799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20511126 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) at 20 Hz, 3 times per week for 4 weeks
Number of subjects: 20
Study 20511126 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 18584527 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromoendoscopy with indigocarmine
Number of subjects: 316
Study 18584527 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (control)
Number of subjects: 316
Study 16028125 — intervention group
Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (approximately 2 x 10^8 cfu)
Number of subjects: 70
Study 16028125 — intervention group
Group type: COMPARATOR
Intervention: Placebo (buffer only)
Number of subjects: 70
Study 16028125 — intervention group
Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine
Number of subjects: 70
Study 15548246 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal and written information in booklet form (experimental group)
Number of subjects: 52
Study 15548246 — intervention group
Group type: COMPARATOR
Intervention: Verbal information only (control group)
Number of subjects: 52
Study 11100017 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.75 microg/day for 6 months plus 1.25 microg/day for 3 months)
Number of subjects: 27
Study 11100017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 11100017 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 27
Study 9171252 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawksley random zero sphygmomanometer (RZS)
Number of subjects: 40
Study 9171252 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinamap monitor
Number of subjects: 40
Study 9171252 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour ambulatory blood pressure monitoring (ABPM)
Number of subjects: 40
Study 9171252 — intervention group
Group type: COMPARATOR
Intervention: ABPM
Number of subjects: 40
Study 9171252 — intervention group
Group type: COMPARATOR
Intervention: Overall blood pressure control
Number of subjects: 40
Study 9171252 — intervention group
Group type: COMPARATOR
Intervention: Gender comparison
Number of subjects: 40
Study 8403810 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak flow variability index (highest peak flow variability within any 1 day during the 12‐day recording period, calculated as the difference between maximum and minimum peak flows expressed as a percentage of the minimum peak flow on that day)
Number of subjects: 147
Study 8403810 — intervention group
Group type: COMPARATOR
Intervention: Standard indices of mean peak flow, forced expiratory volume in 1.0 s, and responsiveness to salbutamol
Number of subjects: 147
Study 2942753 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 41
Study 2942753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 2893527 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (1.45 +/- 1.66 micrograms/kg/min)
Number of subjects: 15
Study 2893527 — intervention group
Group type: COMPARATOR
Intervention: Nitroprusside (2.99 +/- 1.59 micrograms/kg/min)
Number of subjects: 15
Study 31196847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg/d)
Number of subjects: 424
Study 28917369 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n=28)
Number of subjects: 68
Study 28917369 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (n=29)
Number of subjects: 68
Study 28917369 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=11)
Number of subjects: 68
Study 25970511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap-group (n=40)
Number of subjects: 80
Study 25970511 — intervention group
Group type: COMPARATOR
Intervention: Wake-group (n=40)
Number of subjects: 80
Study 24156505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 145
Study 24156505 — intervention group
Group type: COMPARATOR
Intervention: Brief Relational Therapy
Number of subjects: 145
Study 21726650 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (5-HT(2)/5-HT(3) receptor antagonist)
Number of subjects: 0
Study 21726650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19497447 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 2342
Study 19497447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2342
Study 16254269 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 311
Study 16254269 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose perfluorocarbon (10 ml/kg)
Number of subjects: 311
Study 16254269 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose perfluorocarbon (20 ml/kg)
Number of subjects: 311
Study 15595715 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone (1 g, two 500 mg tablets)
Number of subjects: 73
Study 15595715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 11424117 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - two-dose/1-month regimen
Number of subjects: 303
Study 11424117 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - three-dose/6-month regimen
Number of subjects: 303
Study 11424117 — intervention group
Group type: COMPARATOR
Intervention: Single antigen vaccine (Recombivax-HB) - three-dose/6-month regimen
Number of subjects: 303
Study 11424117 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - three-dose/6-month regimen in at-risk adults
Number of subjects: 303
Study 9024733 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 156
Study 9024733 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 156
Study 9024733 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 160 mg/day
Number of subjects: 156
Study 8331091 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 46
Study 8331091 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 46
Study 8331091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 3653085 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction catheter placed in the pharynx for scavenging nitrous oxide
Number of subjects: 14
Study 3653085 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation anaesthetics during bronchoscopy
Number of subjects: 14
Study 3653085 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia or local anaesthesia
Number of subjects: 14
Study 29540326 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg twice daily and aspirin
Number of subjects: 6391
Study 29540326 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 6391
Study 29540326 — intervention group
Group type: EXPERIMENTAL
Intervention: MALE index event
Number of subjects: 6391
Study 25820682 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal mesh repair
Number of subjects: 86
Study 24390808 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training (2 days/week for 12 months)
Number of subjects: 258
Study 24390808 — intervention group
Group type: COMPARATOR
Intervention: Control (maintained usual physical activities)
Number of subjects: 258
Study 23084789 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 100 mg daily
Number of subjects: 48
Study 23084789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 20948589 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted partial turbinoplasty
Number of subjects: 268
Study 20948589 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency-assisted partial turbinoplasty
Number of subjects: 268
Study 17913498 — intervention group
Group type: EXPERIMENTAL
Intervention: Relatives' clinic offered to next-of-kin of Critical Care patients
Number of subjects: 321
Study 17913498 — intervention group
Group type: COMPARATOR
Intervention: Control group (no relatives' clinic)
Number of subjects: 321
Study 16972716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive designs in clinical trials
Number of subjects: 0
Study 16972716 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory Seamless Phase II/III Clinical trials
Number of subjects: 0
Study 12544908 — intervention group
Group type: EXPERIMENTAL
Intervention: PolyHeme
Number of subjects: 0
Study 12544908 — intervention group
Group type: COMPARATOR
Intervention: PRBCs
Number of subjects: 0
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Echovist with Valsalva maneuver
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Echovist with coughing
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Echovist with standardized Valsalva maneuver
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline with Valsalva maneuver
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Echovist
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 46
Study 10471431 — intervention group
Group type: EXPERIMENTAL
Intervention: TCD with 2 provocation maneuvers using Echovist
Number of subjects: 46
Study 10471431 — intervention group
Group type: COMPARATOR
Intervention: TCD
Number of subjects: 46
Study 8935119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritipenem acoxil (RIPM-AC) 200 mg, t.i.d. for 14 days
Number of subjects: 202
Study 8935119 — intervention group
Group type: COMPARATOR
Intervention: Cefotiam hexetil (CTM-HE) 400 mg, t.i.d. for 14 days
Number of subjects: 202
Study 8935119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritipenem acoxil (RIPM-AC)
Number of subjects: 202
Study 8935119 — intervention group
Group type: COMPARATOR
Intervention: Cefotiam hexetil (CTM-HE)
Number of subjects: 202
Study 1935294 — intervention group
Group type: EXPERIMENTAL
Intervention: Postural drainage and forced expiration technique (PD + FET)
Number of subjects: 10
Study 1935294 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure (PEP-mask) and forced expiration technique (PEP + FET)
Number of subjects: 10
Study 1935294 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 6129141 — intervention group
Group type: EXPERIMENTAL
Intervention: Prizidilol 150 mg
Number of subjects: 8
Study 6129141 — intervention group
Group type: EXPERIMENTAL
Intervention: Prizidilol 300 mg
Number of subjects: 8
Study 6129141 — intervention group
Group type: EXPERIMENTAL
Intervention: Prizidilol 600 mg
Number of subjects: 8
Study 6129141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 29326421 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 ml 1000 IU vitamin D3-fortified milk daily for 9 weeks
Number of subjects: 102
Study 29326421 — intervention group
Group type: COMPARATOR
Intervention: 250 ml unfortified milk daily for 9 weeks
Number of subjects: 102
Study 26852887 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate mobilisation
Number of subjects: 43
Study 26852887 — intervention group
Group type: COMPARATOR
Intervention: Dorsal wrist cast for 2 weeks
Number of subjects: 43
Study 26852887 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study 25454120 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term therapy
Number of subjects: 251
Study 25454120 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term therapy
Number of subjects: 251
Study 23292054 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant care
Number of subjects: 160
Study 23292054 — intervention group
Group type: COMPARATOR
Intervention: ERPC under general anaesthesia
Number of subjects: 160
Study 20409359 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention focusing on nutrition education and increasing fruit and vegetable intake; implemented in collaboration with teachers.
Number of subjects: 106
Study 20409359 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention focusing on nutrition education; implemented in collaboration with teachers.
Number of subjects: 106
Study 20409359 — intervention group
Group type: COMPARATOR
Intervention: Control schools with no intervention.
Number of subjects: 106
Study 17646746 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric IOL
Number of subjects: 24
Study 17646746 — intervention group
Group type: COMPARATOR
Intervention: Spherical IOL
Number of subjects: 24
Study 16128648 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine titration
Number of subjects: 39
Study 16128648 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous morphine titration
Number of subjects: 39
Study 12209866 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Inoculation Training with Prolonged Exposure (SITPE)
Number of subjects: 24
Study 12209866 — intervention group
Group type: COMPARATOR
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 24
Study 9867157 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallium-67 renal scan positive group
Number of subjects: 47
Study 9867157 — intervention group
Group type: COMPARATOR
Intervention: Gallium-67 renal scan negative group
Number of subjects: 47
Study 7638802 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the phrenic nerves
Number of subjects: 16
Study 2765808 — intervention group
Group type: EXPERIMENTAL
Intervention: Human thrombin (0.2-0.3 ml, 100-150 units per injection) plus 5% ethanolamine oleate
Number of subjects: 50
Study 2765808 — intervention group
Group type: EXPERIMENTAL
Intervention: Human thrombin plus 5% ethanolamine oleate
Number of subjects: 50
Study 2765808 — intervention group
Group type: COMPARATOR
Intervention: Thrombin - group (control)
Number of subjects: 50
Study 1093756 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (640 mg daily for two months)
Number of subjects: 38
Study 1093756 — intervention group
Group type: COMPARATOR
Intervention: Diuretic induced salt depletion
Number of subjects: 38
Study 1093756 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol after salt depletion
Number of subjects: 38
Study 1093756 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol in patients with moderate renal failure
Number of subjects: 38
Study 1093756 — intervention group
Group type: COMPARATOR
Intervention: Salt depletion by furosemide in renal failure patients
Number of subjects: 38
Study 1093756 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol after salt depletion in renal failure patients
Number of subjects: 38
Study 31724530 — intervention group
Group type: EXPERIMENTAL
Intervention: R2PHF 0.0625 mg
Number of subjects: 31
Study 31724530 — intervention group
Group type: EXPERIMENTAL
Intervention: R2PHF 0.25 mg
Number of subjects: 31
Study 31724530 — intervention group
Group type: EXPERIMENTAL
Intervention: R2PHF 0.50 mg
Number of subjects: 31
Study 31724530 — intervention group
Group type: EXPERIMENTAL
Intervention: R2PHF 1.0 mg
Number of subjects: 31
Study 31724530 — intervention group
Group type: COMPARATOR
Intervention: PHC 1.0 mg
Number of subjects: 31
Study 31724530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 27528707 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted nurse‐led case finding for CVD prevention
Number of subjects: 2926
Study 27528707 — intervention group
Group type: COMPARATOR
Intervention: Unexposed period (no intervention)
Number of subjects: 2926